Thomas J. Gergel, MD

Guthrie Provider


Care Provider Overall: 
Provider Reviews: 

Schedule a visit with this provider

Call 866-GUTHRIE (866-488-4743) to make an appointment.

Ask us if a telemedicine appointment is right for you.

Click here for more information.

  • Clinical Details
  • Education
  • Clinical Trials
Hospital Privileges: 
  • Guthrie Robert Packer Hospital
Clinical Interests: 
  • Brain tumors
  • Breast Cancer
  • Lung Cancer
  • Stereotactic radiation therapy

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of Recommending Care Provider: 
Care Provider Efforts to Include in Decisions: 
Care Provider's Concern for Questions and Worries: 
Care Provider's Explanations of Condition/Problem: 
Care Provider's Friendliness and Courtesy: 
  • Roswell Park Cancer Institute, Buffalo, N.Y. (Radiation Oncology)
  • American Board of Radiology
  • University of Buffalo School of Medicine, Buffalo, N.Y.
  • Hinsdale Hospital, Hinsdale, Ill. (Family Medicine)
Department: Oncology
Diagnosis: Brain
Principal Investigator: Gergel MD, Thomas
Details (Identifier #): NCT04114981
Title: A071801: Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared with Fractionated SRS (FSRS) for Resected Metastatic Brain Disease
Department: Oncology
Diagnosis: Breast
Principal Investigator: Gergel MD, Thomas
Details (Identifier #): NCT03414970
Title: A221505, Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: Gergel MD, Thomas
Sponsor: NRG
Details (Identifier #): NCT0313771
Title: NRG-LU002: Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Department: Oncology
Diagnosis: Breast- Adjuvant
Principal Investigator: Gergel MD, Thomas
Sponsor: NRG
Details (Identifier #): NCT01872975
Title: NSABP-B-51: A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Guthrie Patient: January 2020
*Dr. Gergel was very understanding and caring. He really listened to me and explained everything thoroughly.
Guthrie Patient: January 2020
*Dr. Gergel is excellent & answers any questions very thoroughly. We are very pleased to have him as our doctor for radiation.
Guthrie Patient: December 2019
Dr. Gergel welcomed and answered all of our questions very thoroughly. We are very pleased with him as a doctor.
Guthrie Patient: December 2019
Good experience.
Guthrie Patient: October 2019
*Dr. Thomas Gergel has wonderful manners. Also his staff.
Guthrie Patient: September 2019
Everyone was very friendly.
Guthrie Patient: August 2019
He is over the top. My son is autistic and well not exactly sure on what all he understands but with the ease of the dr and moms help we will start this and get it done.
Guthrie Patient: September 2018
At this time I have a total - confidence in him & his knowledge of my condition. I have not had a 2nd conference with him & will be concluding my radiation so do not know what I will expect from him in the future, etc. Highly satisfied so far.
Guthrie Patient: July 2018
Guthrie Patient: March 2018
Very good, very thorough.